Berry Genomics Co.,Ltd (SHE:000710)
China · Delayed Price · Currency is CNY 9.41
+0.20 (2.17%)
Nov 2, 2026, 2:25 PM CST
Berry Genomics Co.,Ltd Revenue
Berry Genomics Co.,Ltd had revenue of 229.83M CNY in the quarter ending September 30, 2026, a decrease of -3.52%. This brings the company's total for the last twelve months to 920.76M, down -2.17% year-over-year. In the year 2025, Berry Genomics Co.,Ltd had annual revenue of 929.82M, down -13.76%. That makes Berry Genomics Co.,Ltd the 20,239th largest company in the world by revenue and 3,721st in China.
Revenue (ttm)
920.76M
Revenue Growth
-2.17%
P/S Ratio
3.54
Revenue / Employee
691.78K
Employees
1,331
Market Cap
3.26B
Revenue by Geography
- China 815.37M 87.0%
- Overseas 122.10M 13.0%
Fiscal year ended Dec 31, 2025 See the full Berry Genomics Co.,Ltd breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 929.82M | -148.35M | -13.76% |
| Dec 31, 2024 | 1.08B | -73.25M | -6.36% |
| Dec 31, 2023 | 1.15B | -216.59M | -15.83% |
| Jan 1, 2023 | 1.37B | -54.17M | -3.81% |
| Jan 1, 2022 | 1.42B | -118.20M | -7.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Runda Medical Technology | 6.52B |
| Maccura Biotechnology Co.Ltd | 2.18B |
| Medicalsystem Biotechnology | 1.68B |
| Shanghai Labway Clinical Laboratory | 1.28B |
| Amoy Diagnostics | 1.20B |
| SMO ClinPlus CO.,LTD. | 819.71M |
| Thalys Medical Technology Group | 709.31M |
| Guangdong Hybribio Biotech | 641.66M |